Voyageur Pharmaceuticals Ltd.
VM.V
TSX
02/28/2025 | 11/30/2024 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | 61.11% | 26.84% | |||
Depreciation & Amortization | -33.33% | 0.00% | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 61.02% | 26.81% | |||
Operating Income | -61.02% | -26.81% | |||
Income Before Tax | -71.41% | -27.12% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -71.41% | -27.12% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -71.41% | -27.12% | |||
EBIT | -61.02% | -26.81% | |||
EBITDA | -61.11% | -26.84% | |||
EPS Basic | -54.17% | -26.32% | |||
Normalized Basic EPS | -53.33% | -25.00% | |||
EPS Diluted | -54.17% | -26.32% | |||
Normalized Diluted EPS | -53.33% | -25.00% | |||
Average Basic Shares Outstanding | 11.57% | -0.04% | |||
Average Diluted Shares Outstanding | 11.57% | -0.04% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |